Dairy products enriched with omega-3s may improve cardiovascular biomarkers, according to new research.
Dairy products enriched with omega-3s may improve cardiovascular biomarkers, according to research published in the journal Clinical Nutrition.
In a double-blind, placebo-controlled crossover trial, researchers at Friedrich Schiller University of Jena in Germany assigned 51 patients to a dairy product with 3 g of omega-3s or a control dairy product, daily. Patients were assigned to each treatment for 15 weeks with a washout period of 10 weeks observed between each treatment.
Using blood and urine samples taken at the beginning and end of each treatment, researchers identified several improvements in cardiovascular biomarkers from omega-3 supplementation. Improvement in total cholesterol and a higher ratio of high-density lipoprotein cholesterol (“good” cholesterol) to low-density lipoprotein cholesterol (“bad” cholesterol) were noted from omega-3 treatment.
To view the study abstract, click here.
Recent animal study finds that Lysoveta may help reduce neonatal brain injury
July 17th 2024A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.
Krill oil supplementation raises Omega-3 Index of Lupus patients in recent study
July 16th 2024The study was conducted at 20 research centers in the United States by Aker BioMarine and the Lupus Clinical Investigators Network with oversight by Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.